Author Archives: Charles Moore

Online App to Help Diagnose Alzheimer’s Enters Initial Trial Stage

A student-led team of researchers at Washington University School of Medicine (WUSM) in St. Louis, Missouri, has developed an online app designed to streamline the process of Alzheimer’s disease diagnosis. It provides physicians with more information about patients before they are evaluated in person, enabling physicians to assess and assist patients…

Oryzon Getting $300,000 to Continue Developing Alzheimer’s Therapy ORY-2001

Oryzon Genomics is receiving $300,000 from the Alzheimer’s Drug Discovery Foundation to continue developing its Alzheimer’s treatment ORY-2001. In exchange, the foundation, which has been a longtime partner of Oryzon, will receive shares of the company’s stock. Oryzon develops epigenetics therapies, which regulate genome function without affecting the makeup of genes…

UsAgainstAlzheimers Seeks to Increase Number of Minorities in Neurological Research

The non-profit UsAgainstAlzheimers organization has started a program that has a key goal of addressing African-American and Latino underrepresentation in neurological research. Recognizing that Alzheimers disproportionately affects people of color, another goal of the program will be to build a national network of doctors, researchers, patients, caregivers and others involved…

Aduhelm Approved